The hub genes identified, especially CCNA2, CCNB2, CDK1, and TOP2A, represent promising biomarker candidates and potential therapeutic targets worthy of further investigation for improving early HCC detection and treatment outcomes. Here, CDK1 is linked to hepatocellular carcinoma.